Purchase Order HHSN272201100060P
- Not listed
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $10,000.00 firm fixed-price purchase order is for DNA sequencing services. The contract has no set-aside designation. Psomagen Inc. is a provider of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, that supports...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $11,381 firm-fixed-price purchase order contract was awarded on July 5, 2011, with a completion date of July 4, 2012. The contract did not have a set-aside designation. Psomagen Inc. is a multiomics contract laboratory that provides a range of genomic and molecular biology services,...
- This federal contract award, valued at $44,940.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a for-profit manufacturer of genomic sequencing and bioinformatics services. The contract is for "SEQUENCING NOVASEQX 25B 150PE, FLOW CELL" and has a firm fixed-price structure with a completion date of November 16, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and has...
- This federal contract award, valued at $9,970.00, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for the provision of genomic and molecular biology services, including whole genome sequencing, RNA sequencing, and epigenome sequencing, to support research initiatives. Psomagen Inc. has established itself as a key provider of genomic services to various federal agencies, particularly within...
- This federal contract award is for $313,500.00 in single cell multiome sequencing services, provided by Psomagen Inc., a subsidiary of Macrogen, Inc. The contract was awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH). The contract is a firm fixed price purchase order with a period of performance through March 1, 2026. Psomagen Inc. is a prime contractor that specializes in delivering a wide range of genomic and molecular biology...
- This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Psomagen Inc. for DNA and RNA sequencing of parental induced pluripotent stem cell (iPSC) lines. The contract has a ceiling value of $38,053.00 and a completion date of December 31, 2019. Psomagen Inc. is a wholly owned subsidiary of the larger company Macrogen, Inc. This award is an example of the sequencing and multi-omics services Psomagen provides to federal agencies...
- This is a federal contract award to Psomagen Inc., a subsidiary of Macrogen, Inc., by the National Institute of Allergy and Infectious Diseases (NIAID) to provide other functions for a total ceiling value of $6,000.00. The contract is a firm-fixed price purchase order with an ultimate completion date of October 23, 2013. Psomagen is a multiomics contract laboratory service and data analysis provider that specializes in delivering a wide range of genomic and molecular biology services to...
- This federal contract award, with a ceiling value of $27,600, was issued by the National Institute of Mental Health (NIMHD) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for bioinformatics services related to RNA/DNA sequencing. Psomagen, a small business, has a history of providing genomic services to various federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and Smithsonian Institution, through both contract and...
- This federal contract award, valued at $4,380.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract is for a "Human & Herpes Virus mRNA Sequencing Project" in accordance with Psomagen's quote. The contract is a Firm Fixed Price purchase order with an ultimate completion date of August 28, 2014. Psomagen Inc. is not a small business, and the contract did not utilize a set-aside. Macrogen,...
This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Psomagen Inc., a wholly-owned subsidiary of Macrogen, Inc. The contract ceiling value is $9,999.30 and it is for DNA sequencing services. The contract is not set aside for any specific business category. Psomagen Inc. is a leading provider of genomic and molecular biology services to federal agencies, including the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and Smithsonian Institution. Through this contract, Psomagen will likely provide a range of advanced sequencing capabilities, such as whole genome sequencing, RNA sequencing, and epigenome sequencing, to support research on topics like neurodegenerative diseases, cancer, and infectious diseases. In addition to this specific contract award, Psomagen and its parent company Macrogen hold two significant Indefinite Delivery Vehicle (IDV) contracts - one with the USDA for specialized sequencing services, and a $500 million IDV with the NIH National Heart, Lung and Blood Institute to establish and operate the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Funding Only Action | ($1) | 9/30/15 | |
| Not listed | Not listed | $10.0k | 11/5/10 |